|
|
 |
|
Viewing report
|
|
 |
 |
Contraceptive Devices: Gap Analysis – Opportunities and Threats in the Contraceptive Device Market
Valid Results, April 2008
This report identifies opportunities in the birth control device market. The following companies are featured in the study: Barr Pharmaceuticals, Berlex Labs, Conceptus, Cooper Surgical, Gyrus ACMI, Organon and Wyeth. This report identifies the opportunities by looking at the importance Ob/Gyn surgeons place on various treatment options, the overall performance of current alternatives and the relative importance of the featured products.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
The number of respondents to this survey is 40. We also have more studies available with increased survey respondents. Please use our Contact Us page for further details on pricing.
Customers who bought this item also bought
Abnormal Uterine Bleeding: Importance, Performance and Relative Position; A Gap Analysis that Identifies Opportunities for GEA Manufacturers
Contraceptive Devices: How is the Performance of Contraceptive Device Manufacturers Perceived by Ob/Gyn surgeons?
The Obstetrics/Gynecology Hormone & Contraceptive Market: Opportunities for Growth, Customer Retention & Increased Efficiency
India Wants Full-Featured Cell phones
The 2009 Report on Oral Contraceptive Preparations of Hormones and Synthetic Substitute Pharmaceuticals: World Market Segmentation by City
Contraceptive Devices: Treatment Characteristics of Obstetrics and Gynecology Surgeons Specializing in Birth Control Procedures
Report on China’s Oral Contraceptive Drugs Industry
The 2009-2014 World Outlook for Oral Contraceptive Preparations of Hormones and Synthetic Substitute Pharmaceuticals
The 2009-2014 Outlook for Oral Contraceptive Preparations of Hormones and Synthetic Substitute Pharmaceuticals in Greater China
The 2009-2014 Outlook for Oral Contraceptive Preparations of Hormones and Synthetic Substitute Pharmaceuticals in Japan
The 2009-2014 Outlook for Oral Contraceptive Preparations of Hormones and Synthetic Substitute Pharmaceuticals in India
Oral Contraception and Hormone Therapy: How is the Performance of Oral Contraceptive and Hormone Therapy Manufacturers Perceived by Ob/Gyn Surgeons?
|
 |
|
|